Historical developments in the research of interferon receptors

被引:20
作者
Krause, Christopher D.
Pestka, Sidney [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA
[2] PBL Biomed Lab, Piscataway, NJ 08854 USA
关键词
history; interferon; receptor; somatic cell genetics; cloning; hybrids; species specificity;
D O I
10.1016/j.cytogfr.2007.06.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferons (IFNs) were discovered 50 years ago independently by Isaacs and Lindemann and by Nagata and Kojima. When it was later realized that IFNs are active at very low concentrations, research began to determine how their powerful effects were generated from such a small initial signal. It has since been established that interferons, as well as all other cytokines, employ cell surface receptors to translate their presence in the serum to a potent cellular response to a viral infection. These receptor complexes are composed of multiple distinct glycosylated transmembrane polypeptides, a number of protein tyrosine kinases, and interact transiently with a large variety of other proteins including transcription factors, phosphatases, signaling repressors, and adaptor proteins coupling the receptor to alternative signaling pathways. Three major receptor complexes exist that are exclusive to each of three major classes of interferon. Even though the effects of each major class of interferon vary physiologically, each receptor complex interacts with its ligand in similar ways and activates similar signaling cascades. In this mini-review, we take a historical perspective at the major events in the characterization of interferon receptors, discussing interesting results that still need to be explained. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:473 / 482
页数:10
相关论文
共 147 条
[1]   IDENTIFICATION OF MESSENGER-RNAS ENCODING 2 DIFFERENT SOLUBLE FORMS OF THE HUMAN INTERFERON ALPHA-RECEPTOR [J].
ABRAMOVICH, C ;
RATOVITSKI, E ;
LUNDGREN, E ;
REVEL, M .
FEBS LETTERS, 1994, 338 (03) :295-300
[2]   HIGH-AFFINITY BINDING OF I-125-LABELED MOUSE INTERFERON TO A SPECIFIC CELL-SURFACE RECEPTOR .4. MOUSE GAMMA INTERFERON AND CHOLERA-TOXIN DO NOT COMPLETE FOR THE COMMON RECEPTOR-SITE OF ALPHA BETA INTERFERON [J].
AGUET, M ;
BELARDELLI, F ;
BLANCHARD, B ;
MARCUCCI, F ;
GRESSER, I .
VIROLOGY, 1982, 117 (02) :541-544
[4]   MOLECULAR-CLONING AND EXPRESSION OF THE HUMAN INTERFERON-GAMMA RECEPTOR [J].
AGUET, M ;
DEMBIC, Z ;
MERLIN, G .
CELL, 1988, 55 (02) :273-280
[5]   ANTIVIRAL EFFECT OF INTERFERON COVALENTLY BOUND TO SEPHAROSE [J].
ANKEL, H ;
CHANY, C ;
GALLIOT, B ;
CHEVALIER, MJ ;
ROBERT, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (08) :2360-2363
[6]   Interferon-γ has dual potentials in inhibiting or promoting cell proliferation [J].
Asao, H ;
Fu, XY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :867-874
[7]   The IFN gamma receptor: A paradigm for cytokine receptor signaling [J].
Bach, EA ;
Aguet, M ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :563-&
[8]   MODULATION OF MURINE AND HUMAN INTERFERON-GAMMA RECEPTOR EXPRESSION BY THEIR LIGANDS OR PHORBOL ESTER [J].
BADER, T ;
WIETZERBIN, J .
CYTOKINE, 1994, 6 (01) :70-78
[9]   Three-dimensional structure of the Stat3β homodimer bound to DNA [J].
Becker, S ;
Groner, B ;
Müller, CW .
NATURE, 1998, 394 (6689) :145-151
[10]  
Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950